307.4

+0.74%↑

CAT

562.61

-1.14%↓

RTX

177.09

+1.19%↑

GEV.US

575.74

+4.7%↑

194.34

-1.07%↓

307.4

+0.74%↑

CAT

562.61

-1.14%↓

RTX

177.09

+1.19%↑

GEV.US

575.74

+4.7%↑

194.34

-1.07%↓

307.4

+0.74%↑

CAT

562.61

-1.14%↓

RTX

177.09

+1.19%↑

GEV.US

575.74

+4.7%↑

194.34

-1.07%↓

307.4

+0.74%↑

CAT

562.61

-1.14%↓

RTX

177.09

+1.19%↑

GEV.US

575.74

+4.7%↑

194.34

-1.07%↓

307.4

+0.74%↑

CAT

562.61

-1.14%↓

RTX

177.09

+1.19%↑

GEV.US

575.74

+4.7%↑

194.34

-1.07%↓

Strona główna・Stock List・India Globalization Capital Inc

India Globalization Capital Inc

Closed

0.36 -5.26

Buy Sell

Overview

Share price change

24h

Current

Min

0.33

Max

0.36

Key metrics
By Trading Economics
Income	-402K -1.6M
Sales	-2K 328K
Profit margin	-487.5
Employees	70
EBITDA	-506K -1.8M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+1116.22% upside

Dividends
By Dow Jones
Next Earnings	10 lis 2025

Market Stats
By TradingEconomics
Market Cap	8M 37M
Previous open	5.62
Previous close	0.36

India Globalization Capital Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 lis 2025, 21:06 UTC

Major Market Movers

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8 lis 2025, 18:10 UTC

Earnings

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8 lis 2025, 13:10 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 lis 2025, 12:00 UTC

Earnings

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8 lis 2025, 10:30 UTC

Earnings

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8 lis 2025, 03:50 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 lis 2025, 03:41 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 lis 2025, 03:07 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 lis 2025, 22:36 UTC

Earnings

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 lis 2025, 22:22 UTC

Earnings

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q Rev $2.95B >CSU.T

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q Net $210M >CSU.T

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q EPS $9.89 >CSU.T

7 lis 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7 lis 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7 lis 2025, 20:59 UTC

Earnings

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7 lis 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7 lis 2025, 20:22 UTC

Earnings

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7 lis 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7 lis 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7 lis 2025, 19:31 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7 lis 2025, 19:17 UTC

Earnings

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7 lis 2025, 19:09 UTC

Earnings

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7 lis 2025, 19:08 UTC

Earnings

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7 lis 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7 lis 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7 lis 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7 lis 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7 lis 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 lis 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Peer Comparison

Price change

India Globalization Capital Inc Forecast

Price Target

By TipRanks

1116.22% upside

12 Months Forecast

Average 4.5 USD 1116.22%

High 4.5 USD

Low 4.5 USD

Based on 1 Wall Street analysts offering 12 month price targets forIndia Globalization Capital Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to India Globalization Capital Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.